Health & Safety Industry Today

Worldwide Black Lung Disease Market is Projected to grow at a CAGR of about 6.9% till 2023

Market Research Future Published a Half Cooked Research Report on Global Black Lung Disease Research Report. Increasing Prevalence of Black Lung Disease and Rising Healthcare Expenditure Will Grow the Global Black Lung Disease Market at a CAGR of 6.9% During the Forecast Period, 2017–2023
Published 26 March 2018

Factors such as increasing prevalence of black lung disease, rising mining activities, growing research and development expenses, and increasing healthcare expenditures drives the global black lung disease. However, factors such as lack of awareness, limited availability of medicinal treatment options, high surgical therapeutics cost for lung transplantation and stem cell therapy is estimated to restrain the market growth during the forecast period.

The global black lung disease market is expected to grow at an approximate CAGR of 6.9% during the forecast period.

However, factors such as lack of awareness, limited availability of medicinal treatment options followed by the high cost of surgical therapeutics including lung transplantation and stem cell therapy are estimated to restrain the market growth during the forecast period. In 2016, the average cost of lung transplantation was expected to be around USD 111, 618.

Get a sample report at https://www.marketresearchfuture.com/sample_request/5711 .

Regional Analysis

The Americas dominate the global black lung disease market. Factors such as a well-developed healthcare sector, huge patient population, increasing healthcare expenditure and presence of the key players within the region drives the market growth. Europe stands second in the global black lung disease market owing to rising government support, huge patient population, and rising healthcare expenditure. Regionally, the European black lung disease market is segmented into Western Europe and Eastern Europe. Western Europe is estimated to lead the regional market due to the presence of developed within the region. Asia Pacific is the fastest growing region for the black lung disease market. due to the presence of a huge patient population, continuously developing healthcare sector, and rising healthcare expenditure. The Middle East & Africa has the least share in the global black lung disease market owing to the presence of poor economies, lack of a developed healthcare sector, stringent government policies, and lack of awareness for the disease, restrains the market growth, especially within the Africa region. A majority of the market of this region is held by the Middle East due to presence of developed economies within the region like Dubai, Kuwait, Saudi Arabia, and others.

Key Players

The key players for the global black lung disease market are Boehringer Ingelheim International GmbH (Germany), GlaxoSmithKline plc (U.K), Novartis AG (Switzerland), Teva Pharmaceutical Industries Ltd. (Israel), AstraZeneca (U.K), Koninklijke Philips N.V. (The Netherlands), GENERAL ELECTRIC (U.S.), Siemens AG (Germany), TOSHIBA CORPORATION (Japan), Medtronic (U.S.), and others.

Browse Complete Report at https://www.marketresearchfuture.com/reports/black-lung-disease-market-5711 .

Asia Pacific is the fastest growing region for the black lung disease market. Factors such as the presence of a huge patient population, continuously developing healthcare sector, and rising healthcare expenditure drives the market growth within the region. In 2017, a study published in the International Journal of Environmental Research and Public Health journal stated that the number of new cases for pneumoconiosis was about 26,873 in 2014, of which about 13,846 (51.52%) accounted for black lung disease.

The Middle East & Africa has the least share in the global black lung disease market. Presence of poor economies, lack of a developed healthcare sector, stringent government policies, and lack of awareness of the disease, restrain the market growth, especially within the Africa region. A majority of the market of this region is held by the Middle East.

About us

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future

P: +1 646 845 9312

W: www.marketresearchfuture.com

sales@marketresearchfuture.com

Other Industry News

Ready to start publishing

Sign Up today!